Title |
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study
|
---|---|
Published in |
Breast Cancer Research and Treatment, September 2014
|
DOI | 10.1007/s10549-014-3133-1 |
Pubmed ID | |
Authors |
Patrizia Vici, Laura Pizzuti, Clara Natoli, Luca Moscetti, Lucia Mentuccia, Angela Vaccaro, Domenico Sergi, Luigi Di Lauro, Patrizia Trenta, Patrizia Seminara, Daniele Santini, Laura Iezzi, Nicola Tinari, Ilaria Bertolini, Valentina Sini, Marcella Mottolese, Diana Giannarelli, Francesco Giotta, Marcello Maugeri-Saccà, Maddalena Barba, Paolo Marchetti, Andrea Michelotti, Isabella Sperduti, Teresa Gamucci |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Colombia | 1 | 1% |
Portugal | 1 | 1% |
Unknown | 88 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 22 | 24% |
Other | 11 | 12% |
Student > Ph. D. Student | 10 | 11% |
Student > Master | 8 | 9% |
Student > Postgraduate | 6 | 7% |
Other | 13 | 14% |
Unknown | 21 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 36% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
Nursing and Health Professions | 6 | 7% |
Agricultural and Biological Sciences | 5 | 5% |
Economics, Econometrics and Finance | 5 | 5% |
Other | 10 | 11% |
Unknown | 26 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2018.
All research outputs
#8,158,001
of 25,837,817 outputs
Outputs from Breast Cancer Research and Treatment
#1,755
of 5,058 outputs
Outputs of similar age
#79,501
of 263,014 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#18
of 50 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 5,058 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,014 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.